← Back to Search

EaseAlert for Sleep Quality in Firefighters

N/A
Recruiting
Led By Joel M Billings, Ph.D.
Research Sponsored by Embry-Riddle Aeronautical University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to post interventions (6 days from baseline). outcome will be assessed over 1 day per intervention.
Awards & highlights

Study Summary

This trial tests a new Fire Fighter Alarming System to measure its impact on sleep & heart rate. Fire fighters wear sleep & heartrate devices & new alarms for 12 days & complete a questionnaire & daily journal entries.

Who is the study for?
This trial is for firefighters over 18 who've worked in their department for at least two months, with a schedule that includes at least one emergency call per night. Participants should be willing to wear monitoring devices and have no prior experience with the EaseAlert system. Chiefs must approve participation.Check my eligibility
What is being tested?
The study tests the EaseAlert Fire Fighter Alerting System (FFAS), which includes wearable devices and optional bed shakers, against traditional fire alarms. It measures cardiovascular response and sleep quality during three phases: baseline, FFAS with alarm, and FFAS alone.See study design
What are the potential side effects?
There may not be typical 'side effects' as seen in drug trials; however, participants might experience changes in sleep patterns or stress levels due to different alerting methods used during the trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to post interventions (6 days from baseline). outcome will be assessed over 1 day per intervention.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to post interventions (6 days from baseline). outcome will be assessed over 1 day per intervention. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Heart Rate (max)
Heart Rate (mean)
Sleep Efficiency
Secondary outcome measures
Pre-bed anxiety/stress
Satisfaction with EaseAlert during Day
Satisfaction with EaseAlert during Night

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single arm - interventionExperimental Treatment2 Interventions

Find a Location

Who is running the clinical trial?

Embry-Riddle Aeronautical UniversityLead Sponsor
National Development and Research Institutes, Inc.OTHER
37 Previous Clinical Trials
12,898 Total Patients Enrolled
Joel M Billings, Ph.D.Principal InvestigatorEmbry-Riddle Aeronautical University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to volunteer for the current trial?

"As per the information on clinicaltrials.gov, this medical study is not presently enrolling patients - the trial was originally posted on January 1st and last edited November 29th of 2022. While participants are currently not being sought for this particular experiment, there are 143 other studies that require volunteers at present."

Answered by AI

What aims is this trial attempting to accomplish?

"This trial's primary outcome of interest is a comparison between pre- and post-intervention heart rate levels. Secondary outcomes include satisfaction with EaseAlert during night/day, as well as changes in participants' pre-bed anxiety/stress over the course of the study. Data will be collected using 10 point VAS Likert scales, with additional open ended questions to capture further details."

Answered by AI
~29 spots leftby May 2025